Article
Medicine, General & Internal
Aline Vitali-Silva, Isabella G. Vuolo, Lara H. Gonzalez, Renata F. Galvao, Silvia G. Farges, Valeria A. Bello, Regina C. Poli-Frederico
Summary: This study aimed to evaluate the effects of using exogenous estrogen on the prevalence of allodynia in women with migraine. The results showed that using combined hormonal contraceptives (CHC) reduced the chances of women experiencing allodynia.
IRISH JOURNAL OF MEDICAL SCIENCE
(2023)
Article
Clinical Neurology
Helga Taylor, Saleh Alhasan, Maha Saleem, Shane Poole, Fei Jiang, Erin E. Longbrake, Riley Bove
Summary: This study aimed to investigate the impact of menstrual cycle and contraception type on symptom fluctuations in females with MS. The results showed that patients using continuous oral contraceptives experienced fewer symptom fluctuations compared to those using other contraception methods.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
(2023)
Article
Cardiac & Cardiovascular Systems
Dain W. Jacob, Aaron M. Voshage, Jennifer L. Harper, Jacqueline K. Limberg
Summary: Acute increases in sympathetic nervous system activity often lead to increased blood pressure and peripheral vasoconstriction. The effect of the menstrual cycle and oral hormonal contraceptive pill phase on the hemodynamic response to sympathetic activity was examined in this study. The results showed that females taking oral contraceptives exhibited paradoxical vasodilation during acute sympathetic activation compared to females with natural menstrual cycles, and this group difference was unaffected by the menstrual/pill phase.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
(2022)
Article
Endocrinology & Metabolism
Elizabeth Hampson, Erin E. E. Morley, Kelly L. L. Evans, Cathleen Fleury
Summary: This study investigated the effects of oral contraceptive use on cognitive function in women and found that it may have some impact, which is related to the composition of the contraceptives used.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Sport Sciences
Essi K. Ahokas, Helen G. Hanstock, Ida Lofberg, Mari Nyman, Piia Wenning, Heikki Kyrolainen, Ritva S. Mikkonen, Johanna K. Ihalainen
Summary: The aim of this study was to investigate within-cycle differences in nocturnal heart rate (HR) and heart rate variability (HRV) in naturally menstruating women (NM) and women using combined hormonal contraceptives (CU) or progestin-only hormonal contraceptives (PU). The results showed that the menstrual cycle and hormonal cycle phases influence autonomic nervous system balance, which is reflected in measurements of nocturnal HR and HRV.
MEDICINE & SCIENCE IN SPORTS & EXERCISE
(2023)
Review
Clinical Neurology
Bianca Raffaelli, Thien Phu Do, Basit Ali Chaudhry, Messoud Ashina, Faisal Mohammad Amin, Hakan Ashina
Summary: Further research is needed to validate the estrogen withdrawal hypothesis in menstrual migraine and understand the complex interplay between estrogen, the trigeminovascular system, and migraine itself. Previous studies are limited by inconsistencies in methods, small sample sizes, and variable case definitions. To address the unmet treatment needs, it is crucial to develop effective management strategies based on a better understanding of the involvement of estrogen withdrawal in menstrual migraine.
JOURNAL OF HEADACHE AND PAIN
(2023)
Review
Endocrinology & Metabolism
Jordan C. Barone, Mitchell P. Butler, Ashley Ross, Anna Patterson, Melissa Wagner-Schuman, Tory A. Eisenlohr-Moul
Summary: Cyclic hormonal variations during the menstrual cycle contribute to multiple central nervous system disorders, such as premenstrual mood disorder, menstrual migraine, and catamenial epilepsy. However, these fields have operated independently without systematic communication. This scoping review examines existing research studies in these disorders to outline hormonal manipulation trials and identify gaps in the literature. Despite the heterogeneity of treatments and study designs, there is significant overlap in the neuroendocrine-based hormone sensitivity among these menstrual cycle-related disorders.
FRONTIERS IN NEUROENDOCRINOLOGY
(2023)
Article
Clinical Neurology
Rita De Sanctis, Alessandro Vigano, Sebastiano Pindilli, Rosalba Torrisi, Armando Santoro
Summary: This study recruited 50 breast cancer patients and found that patients with migraines and tension-type headaches were more likely to have HER2+ breast cancer, while patients with active migraines had higher estrogen receptor expression.
NEUROLOGICAL SCIENCES
(2022)
Article
Obstetrics & Gynecology
Aaron Lazorwitz, Morgan Pena, Jeanelle Sheeder, Stephanie Teal
Summary: The pharmacokinetic interaction between topiramate and etonogestrel in contraceptive implant users resulted in decreased serum etonogestrel concentrations, potentially impacting contraceptive efficacy.
OBSTETRICS AND GYNECOLOGY
(2022)
Article
Physiology
Juliana Antero, Steven Golovkine, Louis Niffoi, Alice Meignie, Tom Chassard, Quentin Delarochelambert, Martine Duclos, Carole Maitre, Hugo Maciejewski, Allison Diry, Jean-Francois Toussaint
Summary: This study investigated the impact of menstrual cycle and hormonal contraception on training, performance, and wellness in elite rowers. The results showed that rowers with a natural cycle and those on hormonal contraception had higher performance evaluations during specific phases, but experienced more menstrual symptoms during certain phases. It is crucial to consider menstrual cycle and hormonal contraception data in the monitoring of female athletes' wellness and training, as these factors can affect their perception and performance.
FRONTIERS IN PHYSIOLOGY
(2023)
Article
Physiology
Ritva S. Taipale-Mikkonen, Anna Raitanen, Anthony C. Hackney, Guro Strom Solli, Maarit Valtonen, Heikki Peltonen, Kerry McGawley, Heikki Kyrolainen, Johanna K. Ihalainen
Summary: The study found that fluctuations in menstrual cycle and hormonal contraceptive cycle do not systematically affect physiological variables monitored during incremental treadmill testing. However, differences in heart rate at AerT and AnaT between EUM and CHC groups suggest that heart rate-based training should be individually prescribed, and recording of MC or HC use during testing is important to explain potential minor changes in variables such as lactate concentrations or HR response.
FRONTIERS IN PHYSIOLOGY
(2021)
Review
Clinical Neurology
Vimala N. Bharadwaj, Frank Porreca, Robert P. Cowan, Shashidhar Kori, Stephen D. Silberstein, David C. Yeomans
Summary: Research suggests that decreased levels of estrogen and OT during menstruation may lead to reduced affinity of OT for OTR, increasing the likelihood of migraine attacks.
Article
Public, Environmental & Occupational Health
Jeffrey T. Jensen, David F. Archer, Carolyn L. Westhoff, Anita L. Nelson, Shelli Graham, Brian Bernick
Summary: This study evaluated the satisfaction of women who had recently used a monthly contraceptive ring or contraceptive pills with a segesterone acetate and ethinyl estradiol contraceptive vaginal system. The results showed high satisfaction with the vaginal system, and most women liked it as much or better than any previous contraceptive method. The ease of use and one-year duration were the most liked features, while ring insertion and feeling it coming out were the most disliked features. The majority of participants had no concerns about using the system for a year and had recommended it to others.
JOURNAL OF WOMENS HEALTH
(2023)
Article
Clinical Neurology
Iris E. Verhagen, Britt W. H. van der Arend, Daphne S. van Casteren, Niels J. S. Thiermann, Evelien Tange, Antoinette MaassenVanDenBrink, Gisela M. Terwindt
Summary: Previous studies have conflicting results on whether the perimenstrual window is associated with an increased susceptibility to migraine attacks with aura. This study found that there is no difference in the prevalence of menstrual migraine between women with migraine with aura and without aura. However, both groups have a similar increased risk of migraine attacks without aura during the perimenstrual window.
Article
Psychiatry
Soren Vinther Larsen, Anders Pretzmann Mikkelsen, Ojvind Lidegaard, Vibe Gedso Frokjaer
Summary: Hormonal sensitivity may contribute to depression risk in women during certain reproductive phases, such as the premenstrual, postpartum, and perimenopausal phases, and when initiating hormonal contraception. This study aimed to investigate whether prior depression associated with the initiation of hormonal contraception is linked to a higher risk of postpartum depression.
